These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 19817929

  • 1. Vanoxerine, a new drug for terminating atrial fibrillation and flutter.
    Matsumoto N, Khrestian CM, Ryu K, Lacerda AE, Brown AM, Waldo AL.
    J Cardiovasc Electrophysiol; 2010 Mar; 21(3):311-9. PubMed ID: 19817929
    [Abstract] [Full Text] [Related]

  • 2. Oral vanoxerine prevents reinduction of atrial tachyarrhythmias: preliminary results.
    Cakulev I, Lacerda AE, Khrestian CM, Ryu K, Brown AM, Waldo AL.
    J Cardiovasc Electrophysiol; 2011 Nov; 22(11):1266-73. PubMed ID: 21615815
    [Abstract] [Full Text] [Related]

  • 3. Ranolazine terminates atrial flutter and fibrillation in a canine model.
    Bhimani AA, Yasuda T, Sadrpour SA, Khrestian CM, Lee S, Zeng D, Belardinelli L, Waldo AL.
    Heart Rhythm; 2014 Sep; 11(9):1592-9. PubMed ID: 25066042
    [Abstract] [Full Text] [Related]

  • 4. Termination of Atrial Flutter and Fibrillation by K201's Metabolite M-II: Studies in the Canine Sterile Pericarditis Model.
    Sadrpour SA, Serhal M, Khrestian CM, Lee S, Fields T, Dittrich HC, Waldo AL.
    J Cardiovasc Pharmacol; 2015 May; 65(5):494-9. PubMed ID: 25636078
    [Abstract] [Full Text] [Related]

  • 5. The gap junction modifier, GAP-134 [(2S,4R)-1-(2-aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic acid], improves conduction and reduces atrial fibrillation/flutter in the canine sterile pericarditis model.
    Rossman EI, Liu K, Morgan GA, Swillo RE, Krueger JA, Gardell SJ, Butera J, Gruver M, Kantrowitz J, Feldman HS, Petersen JS, Haugan K, Hennan JK.
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1127-33. PubMed ID: 19252062
    [Abstract] [Full Text] [Related]

  • 6. Azd7009: a new antiarrhythmic drug with predominant effects on the atria effectively terminates and prevents reinduction of atrial fibrillation and flutter in the sterile pericarditis model.
    Goldstein RN, Khrestian C, Carlsson L, Waldo AL.
    J Cardiovasc Electrophysiol; 2004 Dec; 15(12):1444-50. PubMed ID: 15610294
    [Abstract] [Full Text] [Related]

  • 7. Randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of a single oral dose of vanoxerine for the conversion of subjects with recent onset atrial fibrillation or flutter to normal sinus rhythm: RESTORE SR.
    Piccini JP, Pritchett EL, Davison BA, Cotter G, Wiener LE, Koch G, Feld G, Waldo A, van Gelder IC, Camm AJ, Kowey PR, Iwashita J, Dittrich HC.
    Heart Rhythm; 2016 Sep; 13(9):1777-83. PubMed ID: 27108936
    [Abstract] [Full Text] [Related]

  • 8. [Modulation of atrioventricular conduction in patients with atrial fibrillation or flutter. Immediate and long-term results].
    Carbucicchio C, Lavarra F, Riva S, Fassini G, Della Bella P.
    Cardiologia; 1995 Dec; 40(12):927-40. PubMed ID: 8901043
    [Abstract] [Full Text] [Related]

  • 9. COR-ART: A multicenter, randomized, double-blind, placebo-controlled dose-ranging study to evaluate single oral doses of vanoxerine for conversion of recent-onset atrial fibrillation or flutter to normal sinus rhythm.
    Dittrich HC, Feld GK, Bahnson TD, Camm AJ, Golitsyn S, Katz A, Koontz JI, Kowey PR, Waldo AL, Brown AM.
    Heart Rhythm; 2015 Jun; 12(6):1105-12. PubMed ID: 25684233
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic accuracy of irregularly irregular RR intervals in separating atrial fibrillation from atrial flutter.
    Krummen DE, Feld GK, Narayan SM.
    Am J Cardiol; 2006 Jul 15; 98(2):209-14. PubMed ID: 16828594
    [Abstract] [Full Text] [Related]

  • 11. Lessons learned from computerized mapping of the atrium. Surgery for atrial fibrillation and atrial flutter.
    Ferguson TB, Schuessler RB, Hand DE, Boineau JP, Cox JL.
    J Electrocardiol; 1993 Jul 15; 26 Suppl():210-9. PubMed ID: 8189128
    [Abstract] [Full Text] [Related]

  • 12. Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents.
    Hongo RH, Themistoclakis S, Raviele A, Bonso A, Rossillo A, Glatter KA, Yang Y, Scheinman MM.
    J Am Coll Cardiol; 2004 Aug 18; 44(4):864-8. PubMed ID: 15312873
    [Abstract] [Full Text] [Related]

  • 13. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
    Chiladakis JA, Kalogeropoulos A, Patsouras N, Manolis AS.
    J Am Coll Cardiol; 2004 Aug 18; 44(4):859-63. PubMed ID: 15312872
    [Abstract] [Full Text] [Related]

  • 14. [The effects of the ablation of atrial flutter in patients with and without a clinical history of paroxysmal atrial fibrillation].
    De Sisti A, Leclercq JF, Fiorello P, Palamara A, Attuel P.
    G Ital Cardiol; 1998 Nov 18; 28(11):1253-60. PubMed ID: 9866803
    [Abstract] [Full Text] [Related]

  • 15. [Sinus node functions, sinoatrial conduction, atrial conductivity after incipient paroxysms of atrial fibrillation and flutter in patients with ischemic heart disease].
    Olesin AI, Shabrov AV, Razumova TV, Sinenko VI, Aleksandrov VS.
    Ter Arkh; 2001 Nov 18; 73(12):40-4. PubMed ID: 11858106
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A logical state model of circus movement atrial flutter role of anatomic obstacles, anisotropic conduction and slow conduction zones on induction, sustenance, and overdrive paced modulation of reentrant circuits.
    Yang H, el-Sherif N, Isber N, Restivo M.
    IEEE Trans Biomed Eng; 1994 Jun 18; 41(6):537-48. PubMed ID: 7927373
    [Abstract] [Full Text] [Related]

  • 20. Randomized study comparing combined pulmonary vein-left atrial junction disconnection and cavotricuspid isthmus ablation versus pulmonary vein-left atrial junction disconnection alone in patients presenting with typical atrial flutter and atrial fibrillation.
    Wazni O, Marrouche NF, Martin DO, Gillinov AM, Saliba W, Saad E, Klein A, Bhargava M, Bash D, Schweikert R, Erciyes D, Abdul-Karim A, Brachman J, Gunther J, Pisano E, Potenza D, Fanelli R, Natale A.
    Circulation; 2003 Nov 18; 108(20):2479-83. PubMed ID: 14610012
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.